Konda B, Sherman EJ, Massarelli E, Nieva J, et al. Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer. J Clin Endocrinol Metab 2024 Aug 12:dgae512. doi: 10.1210.
PMID: 39133806